![X Symposium of Medicinal Chemistry Young Researchers in Spain](http://www.imperial.ac.uk/ImageCropToolT4/imageTool/uploaded-images/newseventsimage_1721729744920_featurenews2012_x1.jpg)
![shadow](http://www.imperial.ac.uk/assets/news/img/image_shadow_sidebar.png)
X Symposium of Med Chem
X Symposium of Medicinal Chemistry Young Researchers in Spain
Tate group member Dr Efthymios Spyridon-Gavriil attends the X Symposium of Medicinal Chemistry Young Researchers in Spain.
X Symposium of Medicinal Chemistry Young Researchers in Spain
Tate group member Dr Efthymios Spyridon-Gavriil attends the X Symposium of Medicinal Chemistry Young Researchers in Spain.
Graduation Day 2024
Congratulations to our PhD students who graduated at the Royal Albert Hall this week!
ZDHHC20 promotes cancer immune evasion, a potential target in pancreatic cancer
Tate & Crick researchers have discovered that S-acyltransferase ZDHHC20 play a role in immune evasion by pancreatic cancer in a paper in Cell Reports.
Discovery of first generation of covalent VHL-recruiting PROTACs
We have reported the first generation of covalent VHL-recruiting PROTACs, now out in J. Med. Chem.
Jana Volarić wins RSC Poster Competition 2024
Tate group member Jana Volaric wins best poster in chemical biology at the RSC Poster competition 2024 held on Linkedin.
Tate Group attends RSC Mastering MedChem VIII 2024 Conference
Various Tate group members including MRes Drug Discovery, Ph.D students, and Postdocs attended the 8th RSC-BMCS Symposium in Burlington House, London.
First small molecule activity-based probes for USP30 discovered
Tate group researchers have produced the first small molecule activity-based probes for USP30.
Nature Reviews Cancer: Protein Lipidation
Ed, Ana and Lior, together with co-authors Prof Hening Lin (Cornell) and Prof Mei Wang-Casey (NUS Singapore) have published a review in Nature Reviews
‘Tate’s Taches’ Raises £1600 for Movember!
Congratulations to the members of the Tate group who took part in Movember 2023.
1st Conference of the European Network for Postdocs in Cancer Research
Tate group member Dr Efthymios Spyridon-Gavriil attends the First Conference of the European Network for Postdocs in Cancer Research